These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 1756224

  • 1. Non-polarized cell surface expression of HLA-A,B,C and HLA-DR antigens in Graves' thyroid follicle cells.
    Mölne J, Nilsson M, Jansson S, Hansson G, Ericson LE.
    Autoimmunity; 1991; 10(3):189-99. PubMed ID: 1756224
    [Abstract] [Full Text] [Related]

  • 2. Adherence of RFD-1 positive dendritic cells to the basal surface of thyroid follicular cells in Graves' disease.
    Mölne J, Jansson S, Ericson LE, Nilsson M.
    Autoimmunity; 1994; 17(1):59-71. PubMed ID: 8025214
    [Abstract] [Full Text] [Related]

  • 3. Induction of microsomal antigen and comparison with histologic localization of HLA-DR in Graves' thyroid tissue.
    Roman SH, Goldsmith NK, Leiderman IZ, Davies TF.
    Autoimmunity; 1989; 2(3):253-63. PubMed ID: 2491609
    [Abstract] [Full Text] [Related]

  • 4. Class II major histocompatibility complex antigen expression and cellular interactions in thyroid glands of Graves' disease.
    Matsunaga M, Eguchi K, Fukuda T, Kurata A, Tezuka H, Shimomura C, Otsubo T, Ishikawa N, Ito K, Nagataki S.
    J Clin Endocrinol Metab; 1986 Apr; 62(4):723-8. PubMed ID: 3081570
    [Abstract] [Full Text] [Related]

  • 5. Nicotinamide and 3-aminobenzamide inhibit recombinant human interferon-gamma-induced HLA-DR antigen expression, but not HLA-A, B, C antigen expression, on cultured human thyroid cells.
    Hiromatsu Y, Sato M, Yamada K, Nonaka K.
    Clin Endocrinol (Oxf); 1992 Jan; 36(1):91-5. PubMed ID: 1532770
    [Abstract] [Full Text] [Related]

  • 6. [Human leukocyte antigen (HLA) complex and anti-thyroidal antibodies in Graves' disease].
    Lacka K, Kordel M, Gembicki M.
    Pol Tyg Lek; 1992 Jan; 44(7-8):179-81. PubMed ID: 2682567
    [Abstract] [Full Text] [Related]

  • 7. Expression of HLA-DR antigens by thyroid cells: the effect of Graves' IgG.
    Bodolay E, Szegedi G, Suranyi P, Juhasz F, Stenszky V, Balazs C, Farid NR.
    Immunol Lett; 1987 May; 15(1):77-81. PubMed ID: 3111991
    [Abstract] [Full Text] [Related]

  • 8. Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity.
    Hanafusa T, Pujol-Borrell R, Chiovato L, Russell RC, Doniach D, Bottazzo GF.
    Lancet; 1983 Nov 12; 2(8359):1111-5. PubMed ID: 6138646
    [Abstract] [Full Text] [Related]

  • 9. Autoimmune and non-autoimmune thyroid diseases have different patterns of cellular HLA class II expression.
    Zantut-Wittmann DE, Boechat LH, Pinto GA, da Silva Trevisan MA, Vassallo J.
    Sao Paulo Med J; 1999 Jul 01; 117(4):161-4. PubMed ID: 10559851
    [Abstract] [Full Text] [Related]

  • 10. Correlation of HLA types and clinical findings in Japanese patients with hyperthyroid Graves' disease: evidence indicating the existence of four subpopulations.
    Inoue D, Sato K, Enomoto T, Sugawa H, Maeda M, Inoko H, Tsuji K, Mori T, Imura H.
    Clin Endocrinol (Oxf); 1992 Jan 01; 36(1):75-82. PubMed ID: 1559302
    [Abstract] [Full Text] [Related]

  • 11. Failure to demonstrate cell-mediated immune responses to thyroid antigens in Graves' disease using in vitro assays of lymphokine-mediated migration inhibition.
    Ludgate ME, Ratanachaiyavong S, Weetman AP, Hall R, McGregor AM.
    J Clin Endocrinol Metab; 1985 Jan 01; 60(1):98-102. PubMed ID: 3871093
    [Abstract] [Full Text] [Related]

  • 12. Ectopic expression of HLA class II antigens on thyroid follicular cells: induction and transfer in vitro by autologous mononuclear leukocytes.
    Khoury EL, Greenspan JS, Greenspan FS.
    J Clin Endocrinol Metab; 1988 Nov 01; 67(5):992-1004. PubMed ID: 2972740
    [Abstract] [Full Text] [Related]

  • 13. Antithyroid drugs inhibit in vivo HLA-DR expression in thyroid follicular cells in Graves' disease.
    Zantut-Wittmann DE, Tambascia MA, da Silva Trevisan MA, Pinto GA, Vassallo J.
    Thyroid; 2001 Jun 01; 11(6):575-80. PubMed ID: 11442005
    [Abstract] [Full Text] [Related]

  • 14. Effects of supernatants of peripheral blood mononuclear cells stimulated by thyroid microsomal antigen on thyrocyte HLA-dr expression in vitro.
    Matsubayashi S, Sakatsume Y, Kasuga Y, Tamai H, Volpé R.
    Autoimmunity; 1990 Jun 01; 8(2):91-6. PubMed ID: 2129496
    [Abstract] [Full Text] [Related]

  • 15. Coexpression of CD40 and class II antigen HLA-DR in Graves' disease thyroid epithelial cells.
    Faure GC, Bensoussan-Lejzerowicz D, Bene MC, Aubert V, Leclere J.
    Clin Immunol Immunopathol; 1997 Aug 01; 84(2):212-5. PubMed ID: 9245555
    [Abstract] [Full Text] [Related]

  • 16. Effect of HLA-DR positive thyrocytes on in vitro thyroid autoantibody production.
    Iwatani Y, Iitaka M, Row VV, Volpé R.
    Clin Invest Med; 1988 Aug 01; 11(4):279-85. PubMed ID: 3262474
    [Abstract] [Full Text] [Related]

  • 17. HLA-DR antigen expression on intrathyroidal lymphocytes and thyrocytes in Hashimoto's thyroiditis and Graves' disease: an immunohistological study.
    Misaki T, Konishi J, Arai K, Iida Y, Kasagi K, Kuma K, Torizuka K.
    Endocrinol Jpn; 1987 Apr 01; 34(2):257-62. PubMed ID: 3113922
    [Abstract] [Full Text] [Related]

  • 18. Pathogenetic relevance of HLA class II expressing thyroid follicular cells in nontoxic Goiter and in Graves' disease.
    Grubeck-Loebenstein B, Londei M, Greenall C, Pirich K, Kassal H, Waldhäusl W, Feldmann M.
    J Clin Invest; 1988 May 01; 81(5):1608-14. PubMed ID: 3130398
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.